Michael F. Price’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Michael F. Price’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-940,000	Closed	-$11.7M	–	129
2016 Q4	$11.7M	Hold	940,000	–	–	1.42%	24
2016 Q3	$12.9M	Sell	940,000 -135,000	-13%	-$1.36M	1.71%	18
2016 Q2	$7.94M	Hold	1,075,000	–	–	1.06%	27
2016 Q1	$6.87M	Buy	1,075,000 +255,000	+31%	+$1.43M	0.96%	27
2015 Q4	$5.13M	Buy	820,000 +103,500	+14%	+$679K	0.63%	45
2015 Q3	$4.18M	Buy	716,500 +166,500	+30%	+$1.28M	0.63%	45
2015 Q2	$4.55M	Hold	550,000	–	–	0.6%	47
2015 Q1	$4.53M	Buy	+550,000	New	+$4.07M	0.6%	43

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

Michael F. Price's ARIA Position: Q1 2017 in Review

Michael F. Price sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 940,000 shares — an estimated $11.7M sold.

Michael F. Price first reported a position in ARIA in Q1 2015 and held it in 8 quarters. The position peaked at $12.9M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Michael F. Price reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Michael F. Price sold 940,000 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $11.7M.
Michael F. Price first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 8 quarters.
Michael F. Price's Ariad Pharmaceuticals Inc position peaked at $12.9M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Michael F. Price's 13F filing for Q1 2017, filed 15 May 2017.